Please send news to Bioconnex



AngioDynamics' consolidation of manufacturing operations to Glens Falls plant is near completion

16 companies interested, only 8 spots left at Albany Med's biomed incubator

AngioDynamics' NanoKnife prolonged pancreatic cancer patients' survival: study

GE Healthcare and The RNA Institute Partner to Create Novel RNAs for the Medical Industry

Pharmaceutical company, Shire, to buy New York developer of an eyedrop for pinkeye for $300M



French pharmaceutical giant invests at least $1.7 billion in Regeneron cancer drug

Regeneron wins FDA approval for cholesterol drug

Two nanotech companies named to Start-Up New York

AngioDynamics projects solid sales growth in 2016

UAlbany researchers to focus more on cyber security, data analytics

AMRI acquires Spanish drug development group for $174 million

NIH names Albany's Wadsworth lab National Center for Adaptive Neurotechnologies

UAlbany's research expenditures increase by nearly $2 million

Pharmacy college scouting properties for student run pharmacy

Pharmacy college secures funding for student-run pharmacy

Biotech company awarded $1 million in grants to kill HIV, Ebola cells



U.S. House acts to repeal medical device tax

SUNY Poly biotech company awarded federal grant to kill infected cells

Albany Med to boost research, create more faculty positions

Delcath appoints chief executive officer



College president will open student-run pharmacy, boost fundraising in second year

Albany Med to award prestigious prize

NIH leads effort to enable precision medicine to revolutionize health care

Drug developer's revenue jumps following recent acquisitions

UAlbany positioning itself to attract more research funding



Federal tax squeezing investments in health care industry

Medical researchers win $500K Albany Medical Center prize

Why a biotech firm is moving to downtown Schenectady

Biotech company moving lab to Schenectady

Deal positions AngioDynamics to re-enter $150 million market

AngioDynamics licenses microsphere treatment technology

Albany drug developer closing U.K. plant


Albany Medical Center to receive $520,000 for biomedical accelerator, seed fund
New York medical device maker reports $17.4 million loss



Albany Med to open accelerator this spring

Regeneron added 265 local workers in 2014

New York medical device maker plans to invest $2.4 million after stock sale

AMRI hires new chief information officer

New York drug developer had $2.82 billion in revenue last year

Albany College of Pharmacy and Health Sciences receives $3M estate gift

New York spends $9.3M tied to AMRI plan to open labs in Buffalo



New CFO at Albany drug developer

Drug developer receives $37 million federal research contract

New York drug developer pays $60 million for U.K. and Indiana businesses

New York drug developer's big money maker had nearly $1.74B in sales last year

Drug maker announces layoffs at New York plant

2014 News >>